Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Conversion Efficiency
Tianjin Tianyao Pharmaceuticals Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.19 Million ≈ $1.93 Million USD) by net assets (CN¥3.89 Billion ≈ $569.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Cash flow conversion efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. This chart illustrates how Tianjin Tianyao Pharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 600488 stock price for real-time trading data and today's change.
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Conversion Ratio Explained
Tianjin Tianyao Pharmaceuticals Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Tianjin Tianyao Pharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tianjin Tianyao Pharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. Also see 600488 market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
NatureCell Co.Ltd
KQ:007390
|
-0.052x |
|
Tianma Bearing Group Co Ltd
SHE:002122
|
0.003x |
|
Wuxi Online Offline Communication Information Technology Co. Ltd.
SHE:300959
|
N/A |
|
Chengdu Bright Eye Hospital Co. Ltd.
SHE:301239
|
N/A |
|
Ningxia Western Venture Industrial Co Ltd
SHE:000557
|
0.016x |
|
Shanxi Guoxin Energy Co Ltd A
SHG:600617
|
0.151x |
|
SmartFinancial, Inc.
NYSE:SMBK
|
0.029x |
|
Xingye Leather Technology Co Ltd
SHE:002674
|
0.049x |
Annual Cash Flow Conversion Efficiency for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
The table below shows the annual cash flow conversion efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. Review 600488 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.89 Billion ≈ $568.62 Million |
CN¥569.37 Million ≈ $83.32 Million |
0.147x | -29.76% |
| 2023-12-31 | CN¥3.75 Billion ≈ $549.23 Million |
CN¥783.01 Million ≈ $114.58 Million |
0.209x | +19.83% |
| 2022-12-31 | CN¥3.75 Billion ≈ $549.30 Million |
CN¥653.52 Million ≈ $95.63 Million |
0.174x | +109.69% |
| 2021-12-31 | CN¥3.82 Billion ≈ $558.53 Million |
CN¥316.89 Million ≈ $46.37 Million |
0.083x | -9.71% |
| 2020-12-31 | CN¥3.77 Billion ≈ $552.05 Million |
CN¥346.88 Million ≈ $50.76 Million |
0.092x | +18.02% |
| 2019-12-31 | CN¥3.59 Billion ≈ $524.74 Million |
CN¥279.37 Million ≈ $40.88 Million |
0.078x | +35.10% |
| 2018-12-31 | CN¥3.28 Billion ≈ $480.28 Million |
CN¥189.27 Million ≈ $27.70 Million |
0.058x | +2315.44% |
| 2017-12-31 | CN¥3.13 Billion ≈ $457.91 Million |
CN¥-8.15 Million ≈ $-1.19 Million |
-0.003x | -110.24% |
| 2016-12-31 | CN¥2.49 Billion ≈ $364.44 Million |
CN¥63.32 Million ≈ $9.27 Million |
0.025x | -51.92% |
| 2015-12-31 | CN¥2.45 Billion ≈ $358.33 Million |
CN¥129.50 Million ≈ $18.95 Million |
0.053x | -29.13% |
| 2014-12-31 | CN¥2.40 Billion ≈ $350.53 Million |
CN¥178.76 Million ≈ $26.16 Million |
0.075x | +105.28% |
| 2013-12-31 | CN¥2.33 Billion ≈ $340.36 Million |
CN¥84.55 Million ≈ $12.37 Million |
0.036x | +385.84% |
| 2012-12-31 | CN¥1.77 Billion ≈ $258.69 Million |
CN¥13.23 Million ≈ $1.94 Million |
0.007x | -83.92% |
| 2011-12-31 | CN¥1.69 Billion ≈ $246.84 Million |
CN¥78.47 Million ≈ $11.48 Million |
0.047x | -35.03% |
| 2010-12-31 | CN¥1.63 Billion ≈ $238.75 Million |
CN¥116.82 Million ≈ $17.09 Million |
0.072x | -74.40% |
| 2009-12-31 | CN¥1.56 Billion ≈ $227.69 Million |
CN¥435.13 Million ≈ $63.67 Million |
0.280x | +91.77% |
| 2008-12-31 | CN¥1.50 Billion ≈ $220.07 Million |
CN¥219.31 Million ≈ $32.09 Million |
0.146x | +31.22% |
| 2007-12-31 | CN¥1.46 Billion ≈ $213.75 Million |
CN¥162.33 Million ≈ $23.75 Million |
0.111x | +136.07% |
| 2006-12-31 | CN¥1.08 Billion ≈ $157.67 Million |
CN¥50.72 Million ≈ $7.42 Million |
0.047x | +145.17% |
| 2005-12-31 | CN¥1.04 Billion ≈ $152.86 Million |
CN¥-108.87 Million ≈ $-15.93 Million |
-0.104x | -193.30% |
| 2004-12-31 | CN¥987.47 Million ≈ $144.50 Million |
CN¥110.30 Million ≈ $16.14 Million |
0.112x | +128.34% |
| 2003-12-31 | CN¥935.65 Million ≈ $136.92 Million |
CN¥45.77 Million ≈ $6.70 Million |
0.049x | -15.24% |
| 2002-12-31 | CN¥784.51 Million ≈ $114.80 Million |
CN¥45.28 Million ≈ $6.63 Million |
0.058x | -42.62% |
| 2001-12-31 | CN¥714.63 Million ≈ $104.57 Million |
CN¥71.87 Million ≈ $10.52 Million |
0.101x | -48.14% |
| 2000-12-31 | CN¥211.75 Million ≈ $30.99 Million |
CN¥41.06 Million ≈ $6.01 Million |
0.194x | -- |
About Tianjin Tianyao Pharmaceuticals Co Ltd
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. The company's primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid r… Read more